According to VistaGen Therapeutics 's latest financial reports the company's current earnings (TTM) are -S$49.79 M. In 2023 the company made an earning of -S$44.22 M an increase over its 2022 earnings that were of -S$83.13 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.